injection site warm; Injection site itchy; injection site red,redness growing at injection site; Soreness at injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications taken by the patient were not provided.  Treatment activities for the event were not provided.   This case was linked to MOD-2021-023395 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jan-2021 and was forwarded to Moderna on 29-Jan-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (injection site red,redness growing at injection site) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications taken by the patient were not provided.  Treatment activities for the event were not provided.   This case was linked to MOD-2021-023395 (Patient Link).